Alessandro Sannino
Corporate Officer/Principal bij University of Salento
Vermogen: 2 410 $ op 31-12-2023
Profiel
Alessandro Sannino is the founder of Academica Life Science SRL, which was founded in 2006.
He is currently the Bioslabs Director at the University of Salento since 2000.
Dr. Sannino was a Co-Inventor & Lead Project Scientist at Gelesis, Inc. from 2008 to 2022 and a Lead Project Scientist at Gelesis Holdings, Inc. from 2022 to 2023.
Dr. Sannino holds a doctorate degree from the University of Washington and Università degli Studi di Napoli Federico II.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GELESIS HOLDINGS, INC.
1.64% | 17-03-2023 | 1 204 879 ( 1.64% ) | 2 410 $ | 31-12-2023 |
Actieve functies van Alessandro Sannino
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Salento | Corporate Officer/Principal | 01-09-2000 |
Eerdere bekende functies van Alessandro Sannino
| Bedrijven | Functie | Einde |
|---|---|---|
| GELESIS HOLDINGS, INC. | Corporate Officer/Principal | 30-10-2023 |
| GELESIS INC | Corporate Officer/Principal | 01-01-2022 |
Academica Life Science SRL
 Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Oprichter | - |
Opleiding van Alessandro Sannino
| University of Washington | Doctorate Degree |
| Università degli Studi di Napoli Federico II | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
Academica Life Science SRL
Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Commercial Services |